Saliva phosphorylated tau concentration is not associated with Alzheimer’s disease, cerebrospinal fluid or blood biomarkers
Helena Sophia Gleerup(Copenhagen University Hospital), Anja Hviid Simonsen(Copenhagen University Hospital), Gunnar Brinkmalm(University of Gothenburg), Jörg Hanrieder(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Juan Lantero‐Rodriguez(University of Gothenburg), Peter Høgh(University of Copenhagen), Steen Gregers Hasselbalch(Rigshospitalet), Thomas K. Karikari(University of Pittsburgh), Laia Montoliu‐Gaya(Sahlgrenska University Hospital), Federica Sanna(University of Gothenburg), Srinivas Koutarapu(University of Gothenburg), Nicholas J. Ashton(King's College London), Henrik Zetterberg(University of Gothenburg), Joel Simrén(University of Gothenburg)
Cited by 1
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k